AMTAGVI
STN: 125773
Proper Name: lifileucel
Trade Name: AMTAGVI
Manufacturer: Iovance Biotherapeutics, Inc.
Indication:
- Treatment of adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor.